Outvise, a Valencia- and Barcelona, Spain-based freelancing recruitment startup, raised €1.2m in funding.
Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a Holon, Israel-based global provider of software solutions for the insurance industry, is to acquire Cálculo, a Madrid, Spain-based vendor of insurance consulting and managed services, and a core solution to the Spanish market.
Whisbi, a Barcelona, Spain-based conversational Sales platform, raised €5M in funding.
ApetEat, a Madrid, Spain-based online food delivery service, raised €1M in funding.
World Mastery, a Barcelona, Spain-based edtech startup, raised €3M in Series A funding.
Rob Surgical, a Barcelona, Spain-based company which designs and develops new robotic systems for minimally invasive surgery, closed a €5m funding round.
AnaCap Financial Partners, a European dedicated financial services specialist investor, closed its fourth Credit Opportunities fund, at €1 billion.
Global professional services company Accenture (NYSE:ACN) acquired Pragsis Bidoop, a Spanish company with expertise in big data, AI and advanced analytics.
Kenmei Technologies, a Valencia, Spain-based specialized company working on mobile network intelligence and automation, raised €1M in seed funding.
Inflight VR, a Barcelona, Spain- and Munich, Germany-based virtual reality startup, closed an investment round that brings total funds raised to date to €4m.
TravelPerk, a Barcelona, Spain-based business travel platform, closed its series C funding round at $104m by adding an additional $60m from existing investors.
Leuko, an MIT-born technology startup developing a non-invasive white blood cell monitoring device, raised $1.8m in seed financing.
Adara Ventures, a venture capital firm based in Luxembourg, completed the first closing of its third fund, with commitments in excess of €65m.
Global financial services group BBVA is launching a new fintech accelerations program.
Sanifit, a Palma, Spain and San Diego, USA-based clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders, closed a €72.2m ($80.9m) funding round.